The Food Safety and Standards Authority of India (FSSAI) announced on Monday that it has taken regulatory measures against nutraceutical manufacturers, including license suspensions, due to serious violations of food safety rules.
FSSAI defines nutraceuticals as a category of products consisting of extracts, isolated, and purified chemical compounds that provide physiological benefits and contribute to maintaining health. These products are made from food ingredients and offer targeted, medicine-like health benefits beyond daily nutrition, and are primarily regulated by FSSAI.
Although part of the industry advocates for stricter regulation of nutraceuticals due to their widespread use, the food sector insists on lighter oversight. Recently, the regulator has intensified inspections of manufacturing facilities, especially in the nutraceutical sector. It identified several manufacturers, products, and violations in a post on Instagram, and also published photos of unhygienic conditions at production sites.
The six companies subjected to FSSAI action include Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare, and Vedant Remedies.
Violations found at specific manufacturers
Violations were found in two products from Airen Herbals. The syrup 'Lycowey Syrup' contained thiamine, vitamin E acetate, copper, selenium, and zinc in concentrations exceeding the established daily recommended intake (RDA) per serving. The product 'Maxford Pain Relief' featured unauthorized claims of knee pain relief and images related to knee pain. Furthermore, the thiamine level exceeded the established RDA per serving, and the declaration of the botanical ingredient did not comply with nutraceutical standards.
The regulator also discovered expired raw materials stored at Aquabliss Lifesciences' facility, along with poor sanitary and hygienic conditions.
In Raskam Healthcare's products, the use of the unapproved ingredient 'Shilajit' was noted, and non-compliance with requirements for maintaining necessary documentation and records was identified.
At Supercure Biotech, the capsules 'Gemkolin 9G softgel' contained 100 mcg of biotin, which exceeds the maximum permissible RDA limit of 40 mcg. The capsule 'Vitamin E softgel capsule' used wheat germ oil instead of Vitamin E, misleading consumers regarding the product name. Additionally, INS food additive numbers were not specified, nor were the Vitamin E limits defined in the Nutraceuticals and New Products (Ni) table.
The 'Superbiotic capsules' contained unresolved and pathogenic strains such as Lactobacillus sporogenes, Streptococcus faecalis, Clostridium butyricum, and Bacillus mesentericus.
Ambico Ayurvedic Healthcare was cited for 'using expired materials or ingredients in the preparation of nutraceuticals and poor sanitary and hygienic conditions at production sites.'
FSSAI reported that artificial flavorings 'Coriander' and 'Strawberry' from Vedant Remedies included the use of expired materials, and also had deficiencies in sanitation, cleaning, and inadequate production infrastructure and testing systems.


